3D打印与切削稳定夹板治疗磨牙症和颞下颌关节紊乱:随机前瞻性单盲交叉试验的研究方案
本试验为单中心前瞻性随机单盲交叉试验,评估3D打印咬合夹板相比切削夹板的非劣效性。两个队列各20例,分别为磨牙症患者和疼痛相关颞下颌关节紊乱患者,随机顺序各佩戴两种夹板3个月,随访2周和3个月。结局包括口腔健康相关生活质量、满意度、疗效和夹板技术结果。
要点
- 3D打印夹板在磨牙症和颞下颌关节紊乱患者中的临床结局是否非劣于切削夹板尚不明确。
- 每例参与者随机顺序佩戴切削和3D打印密歇根型稳定夹板各3个月,随访2周和3个月。
- 结局包括口腔健康影响概况(OHIP-G14)、视觉模拟量表满意度、疗效(对颌牙磨损、疼痛/残疾)和夹板技术结果。
核心结论
- 试验将提供3D打印稳定夹板与切削夹板临床结局的重要信息,有助于基于证据决定支持或反对某一制作工艺。
研究设计与样本
- 单中心前瞻性随机单盲交叉试验,两个队列各20例:一队列为磨牙症参与者,另一队列为疼痛相关颞下颌关节紊乱参与者(肌痛、肌筋膜痛或颌肌/颞下颌关节痛,根据DC/TMD诊断)。
- 密歇根型稳定夹板采用数字化流程制作,使用CE标记材料在其预期用途内进行切削或3D打印。
- 参与者随机顺序佩戴切削夹板和3D打印夹板各3个月,随访2周和3个月。
关键数值与推荐
- 评估结局包括口腔健康相关生活质量(OHIP-G14)、视觉模拟量表满意度、疗效和夹板技术结果。
- 疗效指对颌牙磨损,在颞下颌关节紊乱组中还包括根据GCPS v2.0和DC/TMD标准临床评估的疼痛/残疾减轻。
- 技术结果指标包括夹板贴合度、磨损和断裂率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nowadays, stabilization splints for the management of bruxism and temporomandibular disorders (TMD) can be produced utilizing a digital workflow comprising a digital impression of the teeth, digital splint design, and computer-aided manufacturing of the splints. The latter is usually a milling process, however, more recently 3D printing gained popularity due to its better cost and time efficiency. It remains unknown whether 3D printed stabilization splints are inferior to milled splints regarding clinical outcomes. METHODS: This clinical trial assesses the non-inferiority of 3D printed occlusal splints compared to milled occlusal splints in a monocentric prospective randomized single-blinded crossover trial with two cohorts. One cohort includes 20 participants with bruxism, the other 20 participants with pain-related TMD, i.e., myalgia, myofascial pain, or arthralgia of the jaw muscles/the temporomandibular joint(s) diagnosed according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). Michigan-type stabilization splints are fabricated in a digital workflow by milling or 3D printing using CE-marked materials within their intended purpose. The participants wear a milled and a 3D printed splint in a randomized order for 3 months each, with follow-up visits after 2 weeks and 3 months. Investigated outcome parameters are oral health-related quality of life (OHRQoL) evaluated by the Oral Health Impact Profile (OHIP-G14), participant satisfaction as rated on a visual analog scale, therapeutic efficacy, and technical result of the splints. In this context, therapeutic efficacy means antagonist wear and-in the TMD group-reduction of pain/disability assessed by the Graded Chronic Pain Scale (GCPS v2.0) and clinical assessment following the DC/TMD standard, while technical outcome measures splint fit, wear and fracture rate. DISCUSSION: The trial will provide important information on the clinical outcome of 3D printed stabilization splints in comparison to milled splints and will, therefore, enable an evidence-based decision in favor of or against a manufacturing process. This, in turn, will guarantee for a maximum of the patient's OHRQoL during splint therapy, therapeutic efficacy, and longevity of the splints. TRIAL REGISTRATION: German Clinical Trials Register (DRKS) DRKS00033904. Registered on March 15, 2024.
引用
- Rabel K, Lüchtenborg J, Linke M, et al. 3D printed versus milled stabilization splints for the management of bruxism and temporomandibular disorders: study protocol for a randomized prospective single-blinded crossover trial. Trials. 2024. PMID: 39238023. doi:10.1186/s13063-024-08437-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。